Patricia Ohana

Directeur Technique/Scientifique/R&D chez The Hebrew University of Jerusalem

Health Technology

Consumer Services

Postes actifs de Patricia Ohana

Sociétés	Poste	Début	Fin
The Hebrew University of Jerusalem	Directeur Technique/Scientifique/R&D	-	-

Sociétés	Poste	Début	Fin
BioCancell Therapeutics, Inc. BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.	Directeur Technique/Scientifique/R&D	-	14/10/2010
	Corporate Officer/Principal	14/10/2010	-

Internationale

Etats-Unis	2
Israël	2

Opérationnelle

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1

Sectorielle

Health Technology	2
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	1
BioCancell Therapeutics, Inc. BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.	Health Technology

Entreprise privées

Health Technology